Terms: = Prostate cancer AND FOXO3, FKHRL1, 2309, ENSG00000118689, MGC31925, MGC12739, FOXO2, FOXO3A, O43524, AF6q21, FKHRL1P2, DKFZp781A0677
100 results:
1. Histone methyltransferase SUV39H2 regulates apoptosis and chemosensitivity in prostate cancer through AKT/FOXO signaling pathway.
Sun D; Guo J; Liang W; Chen Y; Wei S; Li A; Wang L; Chen X
Med Oncol; 2024 Jan; 41(2):44. PubMed ID: 38170382
[TBL] [Abstract] [Full Text] [Related]
2. Sinularin stabilizes foxo3 protein to trigger prostate cancer cell intrinsic apoptosis.
Meng XY; Wang KJ; Ye SZ; Chen JF; Chen ZY; Zhang ZY; Yin WQ; Jia XL; Li Y; Yu R; Ma Q
Biochem Pharmacol; 2024 Feb; 220():116011. PubMed ID: 38154548
[TBL] [Abstract] [Full Text] [Related]
3. CSNK1D-mediated phosphorylation of HNRNPA2B1 induces miR-25-3p/miR-93-5p maturation to promote prostate cancer cell proliferation and migration through m
Qi F; Shen W; Wei X; Cheng Y; Xu F; Zheng Y; Li L; Qin C; Li X
Cell Mol Life Sci; 2023 May; 80(6):156. PubMed ID: 37208565
[TBL] [Abstract] [Full Text] [Related]
4. Sympathetic β
Zhang M; Chen F; Sun X; Huang Y; Zeng Y; Chen J; Wu S; Xu C
Biochem Biophys Res Commun; 2023 May; 657():69-79. PubMed ID: 36989842
[TBL] [Abstract] [Full Text] [Related]
5. foxo3a-ROS pathway is involved in androgen-induced proliferation of prostate cancer cell.
Tao Y; Liu S; Lu J; Fu S; Li L; Zhang J; Wang Z; Hong M
BMC Urol; 2022 Apr; 22(1):70. PubMed ID: 35488328
[TBL] [Abstract] [Full Text] [Related]
6. Association of
Yu C; Hodge AM; Wong EM; Joo JE; Makalic E; Schmidt D; Buchanan DD; Hopper JL; Giles GG; Southey MC; Dugué PA
Cells; 2021 Dec; 10(12):. PubMed ID: 34943892
[TBL] [Abstract] [Full Text] [Related]
7. foxo3a and Its Regulators in prostate cancer.
Habrowska-Górczyńska DE; Kozieł MJ; Kowalska K; Piastowska-Ciesielska AW
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830408
[TBL] [Abstract] [Full Text] [Related]
8. SPOP mutation induces DNA methylation via stabilizing GLP/G9a.
Zhang J; Gao K; Xie H; Wang D; Zhang P; Wei T; Yan Y; Pan Y; Ye W; Chen H; Shi Q; Li Y; Zhao SM; Hou X; Weroha SJ; Wang Y; Zhang J; Karnes RJ; He HH; Wang L; Wang C; Huang H
Nat Commun; 2021 Sep; 12(1):5716. PubMed ID: 34588438
[TBL] [Abstract] [Full Text] [Related]
9. MiR-223-3p targets foxo3a to inhibit radiosensitivity in prostate cancer by activating glycolysis.
Zhou K; Wei Y; Li X; Yang X
Life Sci; 2021 Oct; 282():119798. PubMed ID: 34237309
[TBL] [Abstract] [Full Text] [Related]
10. [foxo3a signaling pathway in prostate cancer: Progress in studies].
Tao Y; Li LL; Liu SH; Hong M
Zhonghua Nan Ke Xue; 2020 Aug; 26(8):745-750. PubMed ID: 33377739
[TBL] [Abstract] [Full Text] [Related]
11. Role of POLE and POLD1 in familial cancer.
Mur P; García-Mulero S; Del Valle J; Magraner-Pardo L; Vidal A; Pineda M; Cinnirella G; Martín-Ramos E; Pons T; López-Doriga A; Belhadj S; Feliubadaló L; Munoz-Torres PM; Navarro M; Grau E; Darder E; Llort G; Sanz J; Ramón Y Cajal T; Balmana J; Brunet J; Moreno V; Piulats JM; Matías-Guiu X; Sanz-Pamplona R; Aligué R; Capellá G; Lázaro C; Valle L
Genet Med; 2020 Dec; 22(12):2089-2100. PubMed ID: 32792570
[TBL] [Abstract] [Full Text] [Related]
12. SETD2 Restricts prostate cancer Metastasis by Integrating EZH2 and AMPK Signaling Pathways.
Yuan H; Han Y; Wang X; Li N; Liu Q; Yin Y; Wang H; Pan L; Li L; Song K; Qiu T; Pan Q; Chen Q; Zhang G; Zang Y; Tan M; Zhang J; Li Q; Wang X; Jiang J; Qin J
Cancer Cell; 2020 Sep; 38(3):350-365.e7. PubMed ID: 32619406
[TBL] [Abstract] [Full Text] [Related]
13. The triphenyltin carboxylate derivative triphenylstannyl 2-(benzylcarbamoyl)benzoate impedes prostate cancer progression via modulation of Akt/foxo3a signaling.
Waseem D; Khan GM; Haq IU; Rashid U; Syed DN
Toxicol Appl Pharmacol; 2020 Aug; 401():115091. PubMed ID: 32525019
[TBL] [Abstract] [Full Text] [Related]
14. Circular RNA_LARP4 inhibits cell migration and invasion of prostate cancer by targeting foxo3A.
Weng XD; Yan T; Liu CL
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5303-5309. PubMed ID: 32495863
[TBL] [Abstract] [Full Text] [Related]
15. Valproic Acid Addresses Neuroendocrine Differentiation of LNCaP Cells and Maintains Cell Survival.
Giordano F; Naimo GD; Nigro A; Romeo F; Paolì A; De Amicis F; Vivacqua A; Morelli C; Mauro L; Panno ML
Drug Des Devel Ther; 2019; 13():4265-4274. PubMed ID: 31908413
[TBL] [Abstract] [Full Text] [Related]
16. Oxidative Stress and cancer Development: Are Noncoding RNAs the Missing Links?
D'Souza LC; Mishra S; Chakraborty A; Shekher A; Sharma A; Gupta SC
Antioxid Redox Signal; 2020 Dec; 33(17):1209-1229. PubMed ID: 31891666
[No Abstract] [Full Text] [Related]
17. Circular RNA circfoxo3 promotes prostate cancer progression through sponging miR-29a-3p.
Kong Z; Wan X; Lu Y; Zhang Y; Huang Y; Xu Y; Liu Y; Zhao P; Xiang X; Li L; Li Y
J Cell Mol Med; 2020 Jan; 24(1):799-813. PubMed ID: 31733095
[TBL] [Abstract] [Full Text] [Related]
18. Reduction of circular RNA foxo3 promotes prostate cancer progression and chemoresistance to docetaxel.
Shen Z; Zhou L; Zhang C; Xu J
Cancer Lett; 2020 Jan; 468():88-101. PubMed ID: 31593800
[TBL] [Abstract] [Full Text] [Related]
19. Depletion of gamma-glutamylcyclotransferase inhibits cancer cell growth by activating the AMPK-foxo3a-p21 axis.
Taniguchi K; Ii H; Kageyama S; Takagi H; Chano T; Kawauchi A; Nakata S
Biochem Biophys Res Commun; 2019 Sep; 517(2):238-243. PubMed ID: 31345573
[TBL] [Abstract] [Full Text] [Related]
20. Circulating IGF-1 promotes prostate adenocarcinoma via foxo3A/BIM signaling in a double-transgenic mouse model.
Wang S; Wang N; Yu B; Cao M; Wang Y; Guo Y; Zhang Y; Zhang P; Yu X; Wang S; Zeng L; Liang B; Li X; Wu Y
Oncogene; 2019 Sep; 38(36):6338-6353. PubMed ID: 31312023
[TBL] [Abstract] [Full Text] [Related]
[Next]
